Risk and fate of residual interatrial shunting after transcatheter closure of patent foramen ovale: A long term follow up study

European Journal of Medical Research

Volumn 16, Issue 1, 2011, Pages 13-19

  Hammerstingl, Christoph ^a   Bauriedel, G ^b   Stusser C ^a   Momcilovic, D ^a   Tuleta, I ^a   Nickenig, G ^a   Skowasch, D ^a  

^a UNIVERSITY OF BONN   (Germany)

^b Kreiskrankenhaus Schmalkalden   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTERY EMBOLISM; ARTICLE; CLINICAL TRIAL; CONTRAST ENHANCEMENT; DEVICE; FEMALE; FOLLOW UP; HEART ANEURYSM; HEART ATRIUM SEPTUM ANEURYSM; HUMAN; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; PATENT FORAMEN OVALE; PATENT FORAMEN OVALE PERCUTANEOUS TRANSCATHETER CLOSURE; PROSPECTIVE STUDY; RESIDUAL INTERATRIAL SHUNTING; RISK FACTOR; SHUNTING; SURGICAL RISK; SURGICAL TECHNIQUE; THROMBOEMBOLISM; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TREATMENT OUTCOME; AIR EMBOLISM; BODY MASS; BRAIN ISCHEMIA; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEVICE EMBOLIZATION; DIABETES MELLITUS; EMBOLISM; HEART EJECTION FRACTION; HEART INFARCTION; HYPERLIPIDEMIA; HYPERTENSION; INCIDENCE; OBSERVATIONAL STUDY; PAROXYSMAL ATRIAL FIBRILLATION; PERCUTANEOUS TRANSCATHETER CLOSURE; PERICARDIAL EFFUSION; SEPTAL OCCLUDER; SMOKING; THROMBOSIS; TRANSIENT ISCHEMIC ATTACK; VALSALVA MANEUVER;

ACETYLSALICYLIC ACID; ANTIVITAMIN K; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

EID: 79951486873     PISSN: 09492321     EISSN: None     Source Type: Journal    
DOI: 10.1186/2047-783x-16-1-13     Document Type: Article

References (24)

1. Homma S, Di Tullio MR, Sacco RL, Mihalatos D, Li MG, Mohr JP. Characteristics of patent foramen ovale associated with cryptogenic stroke. A biplane transesophageal echocardiographic study. Stroke 1994; 25(3):582-586.
2. Homma S, Sacco RL. Patent foramen ovale and stroke. Circulation 2005; 112(7):1063-1072.
3. Lechat P, Mas JL, Lascault G, Loron P, Theard M, Klimczac M et al. Prevalence of patent foramen ovale in patients with stroke. N Engl J Med 1988; 318(18):1148-1152.
4. Windecker S, Meier B. Is closure recommended for patent foramen ovale and cryptogenic stroke? Patent foramen ovale and cryptogenic stroke: to close or not to close? Closure: what else! Circulation 2008; 118(19):1989-1998.
5. Homma S, Sacco RL, Di Tullio MR, Sciacca RR, Mohr JP. Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in Cryptogenic Stroke Study. Circulation 2002; 105(22):2625-2631.
6. Bruch L, Parsi A, Grad MO, Rux S, Burmeister T, Krebs H et al. Transcatheter closure of interatrial communications for secondary prevention of paradoxical embolism: single-center experience. Circulation 2002; 105(24):2845-2848.
7. Braun MU, Fassbender D, Schoen SP, Haass M, Schraeder R, Scholtz W et al. Transcatheter closure of patent foramen ovale in patients with cerebral ischemia. J Am Coll Cardiol 2002; 39(12):2019-2025.
8. Webster MW, Chancellor AM, Smith HJ, Swift DL, Sharpe DN, Bass NM et al. Patent foramen ovale in young stroke patients. Lancet 1988; 2(8601):11-12.
9. Schwerzmann M, Windecker S, Wahl A, Mehta H, Nedeltchev K, Mattle H et al. Percutaneous closure of patent foramen ovale: impact of device design on safety and efficacy. Heart 2004; 90(2):186-190.
10. Braun M, Gliech V, Boscheri A, Schoen S, Gahn G, Reichmann H et al. Transcatheter closure of patent foramen ovale (PFO) in patients with paradoxical embolism. Periprocedural safety and mid-term follow-up results of three different device occluder systems. Eur Heart J 2004; 25(5):424-430.
11. Cifarelli A, Musto C, Parma A, Pandolfi C, Pucci E, Fiorilli R et al. Long-term outcome of transcatheter patent foramen ovale closure in patients with paradoxical embolism. Int J Cardiol 2010; 141(3):304-310.
12. Anzola GP, Morandi E, Casilli F, Onorato E. Does transcatheter closure of patent foramen ovale really "shut the door?" A prospective study with transcranial Doppler. Stroke 2004; 35(9):2140-2144.
13. Daniel WG. Transcatheter closure of patent foramen ovale. Therapeutic overkill or elegant management for selected patients at risk? Circulation 1992; 86(6):2013-2015.
14. Droste DW, Silling K, Stypmann J, Grude M, Kemeny V, Wichter T et al. Contrast transcranial doppler ultrasound in the detection of right-to-left shunts : time window and threshold in microbubble numbers. Stroke 2000; 31(7): 1640-1645.
15. Schuchlenz HW, Saurer G, Weihs W. Patent foramen ovale, atrial septal aneurysm, and recurrent stroke. N Engl J Med 2002; 346(17):1331-1332.
16. von Bardeleben RS, Richter C, Otto J, Himmrich L, Schnabel R, Kampmann C et al. Long term follow up after percutaneous closure of PFO in 357 patients with paradoxical embolism: Difference in occlusion systems and influence of atrial septum aneurysm. Int J Cardiol 2009; 134(1):33-41.
17. Windecker S, Wahl A, Chatterjee T, Garachemani A, Eberli FR, Seiler C et al. Percutaneous closure of patent foramen ovale in patients with paradoxical embolism: long-term risk of recurrent thromboembolic events. Circulation 2000; 101(8):893-898.
18. Meier B, Lock JE. Contemporary management of patent foramen ovale. Circulation 2003; 107(1):5-9.
19. Messe SR, Silverman IE, Kizer JR, Homma S, Zahn C, Gronseth G et al. Practice parameter: recurrent stroke with patent foramen ovale and atrial septal aneurysm: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2004; 62(7):1042-1050.
20. Messe SR, Kasner SE. Is closure recommended for patent foramen ovale and cryptogenic stroke? Patent foramen ovale in cryptogenic stroke: not to close. Circulation 2008; 118(19):1999-2004.
21. Mohr JP, Homma S. Patent cardiac foramen ovale: stroke risk and closure. Ann Intern Med 2003; 139(9):787-788.
22. O'Gara PT, Messe SR, Tuzcu EM, Catha G, Ring JC. Percutaneous device closure of patent foramen ovale for secondary stroke prevention: a call for completion of randomized clinical trials: a science advisory from the American Heart Association/American Stroke Association and the American College of Cardiology Foundation. Circulation 2009; 119(20):2743-2747.
23. Khairy P, O'Donnell CP, Landzberg MJ. Transcatheter closure versus medical therapy of patent foramen ovale and presumed paradoxical thromboemboli: a systematic review. Ann Intern Med 2003; 139(9):753-760.
24. Coats AJ. Ethical authorship and publishing. Int J Cardiol 2009; 131(2):149-150.